We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Argent Biopharma packs its bags for London on a one-way ticket Patrys shares slump 50% on cancellat...
Read ArticleBionomics (ASX:BNO) has announced positive topline results from its Phase 2b ATTUNE trial of...
Read ArticleATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleASX 200 benchmark ends big day of earnings near parity, Small Ordinaries (XSO) climbs 0.5% Tech Sec...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe ASX 200 benchmark has climbed down from highs at lunch to finish on +0.39%. Health Care was we...
Read ArticleASX benchmark falls 0.86% for the day, dragged down by bad news from China. Telcos, Energy and Inf...
Read ArticleASX sleepwalks to an underwhelming -0.3% loss for the day. Real Estate the ‘highlight’, on a paltr...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleThe ASX 200 has had its worst day in roughly a month with a 1.29 percentage dip The sectors were a...
Read ArticleThe ASX 200 had a positive finish to the day on the whole, on the back of the rates pause from the...
Read ArticleThe ASX couldn’t make up its mind, a bit like economists looking ahead to the RBA decision tomorrow...
Read ArticleThe ASX 200 put on a much better show today, with a +0.46% gain at closing time Sectors wise, Mater...
Read ArticleBod Science to go ahead with Aqua Phase acquisition after study results Osteopore to ramp up China...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe ASX 200 closed -0.10% in the red today, after feeling flat all day Sectors wise, Energy stocks...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleAmid the hype about using artificial intelligence (AI) for anything from robotic call centres to wri...
Read ArticleThe S&P ASX 200 closes down 0.2%, while the S&P XEC fell 0.61 Larvotto Resources and OD6 Me...
Read ArticleThe ASX jumped 0.3% after lunch as the RBA finally kept rates on hold. XGD All Ordinaries Gold soar...
Read ArticleAussie bourse has worst day since November 3 with S&P ASX 200 down 2.28% Even darling lithium s...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX 200 adds just 0.1% because it was literally the least it could do. Aussie tech stock surge nega...
Read ArticleBionomics (ASX:BNO) has announced the release of an analysis of the data from its Phase 2 PR...
Read ArticleASX scuttled by bleak rates outlook in the US, down 0.83% for the day RBA boss Philip Lowe had bett...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleLittle joy for investors in December with traditional Christmas rally not eventuating in 2022 Meteo...
Read ArticleBionomics (ASX:BNO) has announced the results from its Phase 2 PREVAIL study to evaluate the...
Read ArticleThe ASX 200 was in the red again, down 0.21% today 9 out 11 sectors finished lower led by Real Esta...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleBiopharmaceutical company, Bionomics (BNO), appoints neuroscientist Dr Spyros Papapetropoulos (MD) a...
Read ArticleRespiri’s wheezo RPM will be installed in New Mexico, USA Beamtree signs new distributor Bionomics...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleBionomics (ASX:BNO) has announced the pricing of an underwritten follow-on offering in the U...
Read ArticleOMG, Tuesdays, amirite? There’s been a lot of info flying around the newsroom today, and a fair bit...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleStockhead’s resident health and biotech expert Tim Boreham is putting down the microscope and pickin...
Read ArticleWhat are the risks of investing in biotechs? How to value a biotech Top 10 crucial trials coming up...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleThe ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsi...
Read ArticleParadigm Biopharmaceuticals’ (ASX:PAR) investment relations guy Simon White is a bit different to yo...
Read ArticleGold aspirant Cavalier Resources announces its new substantial shareholders following IPO Gold stoc...
Read ArticleNordic Nickel announces its new substantial shareholders following its June 2 debut Sigma Healthcar...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleTrading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers a...
Read ArticleADELAIDE, Australia, Jan. 12, 2022 /PRNewswire/ — Bionomics Limited (ASX:BNO, NASDAQ:BNOX) (Bionomic...
Read ArticleBionomics Limited (BNO) announces the issuance of 243,300 American Depositary Shares (ADSs), to exe...
Read ArticleUS stocks fell hard as Fed outlines rate cut plan There were more investor jitters over interest rat...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleThe ASX started the week lower as a result of a drop in the energy and financial sectors. Energy sha...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleADELAIDE, Australia, Dec. 16, 2021 /PRNewswire/ — Bionomics Limited (Bionomics or Company), a clinic...
Read ArticleWhile US markets rose after the Fed outlined plans to gradually withdraw stimulus, our markets did n...
Read ArticleThe ASX 200 Health Index (XHJ) is trading higher by 0.27% at the time of writing, compared to the br...
Read ArticleUS stocks fall ahead of Fed meeting On Wall Street, all three major benchmarks finished lower ahead...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleThe ASX closed the fourth last week before Christmas up for the day, but once again down for the wee...
Read ArticleBionomics (ASX:BNO) has announced that the US FDA has granted Fast Track designation to the...
Read ArticleADELAIDE, Australia, Dec. 1, 2021 /PRNewswire/ – Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleBenchmark US indices closed mixed on Tuesday, November 23, as technology stocks declined, and bond y...
Read ArticleADELAIDE, Australia, Nov. 23, 2021 /PRNewswire/ — Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomic...
Read ArticleThe ASX 200 Health Index (XHJ) is up by 0.80% at the time of writing, compared to the broader index...
Read ArticleBionomics (ASX:BNO) has received US FDA clearance to proceed with evaluating its lead clinic...
Read ArticleU.S. FDA clearance of IND for BNC210 evaluation as an acute treatment for patients with Social Anx...
Read ArticleThe ASX started flat and closed flat as local markets struggled for direction in Thursday trade. By...
Read ArticleIt was a fairly turbulent night on global markets, but the ASX 200 put in a fairly solid day of trad...
Read ArticleThe broad Australian indices have started the day off in the red as the market resets from a number...
Read ArticleClinical-stage biopharmaceutical company Bionomics (ASX:BNO) has announced it will proceed w...
Read ArticleRapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatme...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt was another positive close for the Australian bourse today with energy the standout sector. The A...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleBionomics (ASX:BNO) has announced that it plans to conduct a registered initial public offer...
Read ArticleADELAIDE, Australia, Aug. 2, 2021 /PRNewswire/ — Bionomics Limited (ASX: BNO, OTCQB: BNOEF), (Bionom...
Read ArticleThe S&P/ASX200 closed up Monday, gaining 98.80 points or 1.34% to 7,491.40 and setting a new 100...
Read ArticleThe biggest winner in health stocks today was Hydrix (ASX:HYD) – up 9.68% off the back of news that...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleAussie shares rebounded today following rises in the US and Europe overnight, after having fallen fo...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleADELAIDE, Australia, July 6, 2021 /PRNewswire/ — Bionomics Limited (ASX: BNO, OTCQB:BNOEF) (Bionomic...
Read ArticleSummary The S&P/ASX200 traded up by 12.60 points or 0.17% at 7,327.60 by Tuesday afternoon....
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleIt was a good day for some of ASX-listed cancer therapy stocks yesterday, with three companies relea...
Read ArticleBionomics (ASX:BNO) has announced it will proceed with evaluating its lead clinical compound...
Read ArticleRapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxi...
Read ArticleSummary Biopharmaceutical company Bionomics Limited will expand its product pipeline for the tre...
Read ArticleWall Street dropped on Friday, but still positive in April On Friday trading, the Dow Jones fell 0.5...
Read ArticleThe capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the fir...
Read ArticleSummary Australian players MGC Pharmaceuticals and ArchTIS limited were under the spotlight foll...
Read ArticleIf you want to know which ASX stocks fund managers and famous investors are putting their money into...
Read ArticleADELAIDE, Australia, April 9, 2021 /PRNewswire/ — Bionomics Limited (ASX: BNO, OTCQB:BNOEF) (Bionomi...
Read ArticleSource: wutzkohphoto, Shutterstock Today, the Australian market traded in the green. The benchmark...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike....
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike....
Read Article2021 is set to be another big year for ASX capital raisings with solid volumes so far in 2021. In th...
Read ArticleThe Bionomics Ltd (ASX: BNO) share price is in positive territory today after announcing a non-reno...
Read ArticleIn February, ASX fintech stocks were winners, losers and winners again. The benchmark ASX 200 index...
Read ArticleSource: ShutterstockProfessional Summary Biotech penny stocks are extremely volatile, given the...
Read ArticleBNC210 novel oral tablet formulation (900 mg given twice daily) exceeds blood exposure projected fo...
Read ArticleIt’s been a dismal day for the market, although small-cap investors can perhaps take some measure of...
Read ArticleBionomics (ASX:BNO) has announced a Memorandum of Understanding with EmpathBio, the wholly-o...
Read ArticleADELAIDE, Australia, Feb. 17, 2021 /PRNewswire/ — Bionomics Limited (ASX: BNO, OTCQB: BNOEF, Germany...
Read ArticleCommitments received for a placement of A$15,991,634 at A$0.145 per share Significant participat...
Read ArticleThe Bionomics Ltd (ASX: BNO) share price continues to climb today after the company announced it ha...
Read ArticleClinical-stage biopharmaceutical company Bionomics (ASX:BNO) has announced that all patients...
Read ArticleThe MODULATE trial is evaluating new experimental approaches to immunotherapy treatment in colorecta...
Read ArticleThe company’s lead drug candidate BNC210 is a novel, proprietary negative allosteric modulator of th...
Read ArticleSummary Bionomics initiates a 7-day, twice-daily dosing pharmacokinetic clinical trial. The com...
Read ArticleAdelaide’s Carina Biotech has announced an agreement to create CAR-T cells targeted at a can...
Read ArticleThe Bionomics Ltd (ASX: BNO) share price has run higher today after the company announced it has en...
Read ArticleBionomics (ASX:BNO) has announced the successful completion of the institutional component o...
Read ArticleA quick wrap of the ASX’s key winners and losers on Friday, August 28. Data is taken after the marke...
Read ArticleA quick wrap of the ASX’s key winners and losers on Thursday, August 27. Data is taken after the mar...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleA quick wrap of the key winners and losers on Tuesday, June 2. Data is taken after the market closes...
Read ArticleThe Bionomics Ltd (ASX: BNO) share price is charging higher today, up 16.67% at the time of writing...
Read ArticleWe know that gambling dens aren’t open in these days of social distancing, but metaphorically speaki...
Read ArticleBionomics (ASX: BIO) has published data regarding its phase 2a trial into using its BNC210 drug to t...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleSo the pot sector around the world is down and you’ve lost $$$. Maybe the way to dig your way out is...
Read ArticleClinical stage biopharmaceutical company Bionomics (ASX: BNO) has completed the sale of two wholly-o...
Read ArticleBionomics (ASX:BNO), a clinical-stage company leveraging proprietary platform technologies t...
Read ArticleBionomics Limited (ASX: BNO) a global clinical stage biopharmaceutical company, has accepted an offe...
Read ArticleHealth care industry is one of the world’s fastest-growing industries, providing services to treat p...
Read ArticleThe Bionomics Ltd (ASX: BNO) share price has been on fire on Monday morning. The clinical stage bio...
Read ArticleClinical stage biopharma company Bionomics (ASX: BNO) is celebrating this morning after being grante...
Read ArticleThe FDA has granted fast-track designation to Bionomics' (ASX:BNO) BNC210 development progra...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleThe three best-performing health and biotech companies in the past fortnight have all seen their sha...
Read ArticleHeadlines are being made in the US today with a Republican Congressman expected to plead guilty to...
Read ArticleIt's been 25 years since the Canberra Raiders have won a premiership. Sadly they knocked out my Bunn...
Read ArticleOn Stockhead today: Aussie small caps trying to tackle the opioid crisis, which car manufacturers wi...
Read ArticleEach Monday, Stockhead recaps which stocks are heavily demanded by investors – or running hot. Stock...
Read ArticleOn Stockhead today, why the ASX thinks the tech IPO story has further to run, McKinsey & Co say...
Read ArticleThe Bionomics Ltd (ASX: BNO) share price shot up 41% today after the biotechnology researcher annou...
Read ArticleShares in Bionomics (ASX:BNO) have flown to their highest point since May as it looks redo the faile...
Read ArticleBiopharma company Bionomics (ASX: BNO) has updated the market with positive news regarding its leadi...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleBionomics (ASX:BNO) has announced positive results from a pharmacokinetic study in healthy v...
Read ArticleComing after trial flops from Factor Therapeutics (ASX:FTT), Innate Immunotherapeutics (now Amplia T...
Read ArticleOn 15 August 2019, the S&P/ASX 200 Health Care Index is down 2.48% to 34,883, while the benchmar...
Read ArticleZelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results f...
Read ArticleCompanies and institutions that provide medical assistance and services, manufactures of medical equ...
Read ArticleBook Value of Equity Per Share (BVEPS) is the sum each common equity shareholder receives at the tim...
Read ArticleIn this week's Weekly Insights (published in two parts):-Do I Have A Few Surprises For (Most Of) You...
Read ArticleThe small-cap or ‘casino’ end of the share market is a veritable minefield suitable for highly-expe...
Read ArticleDimerix Limited (ASX: DXB) Clinical-stage biopharmaceutical company, Dimerix Limited (ASX: DXB) is e...
Read ArticleOne of the worst performers on the Australian share market on Wednesday has been the Bionomics Ltd (...
Read ArticleAt the start of every trading day, it can be useful to know which stocks are humming out of the gate...
Read ArticleAt time of writing, Bionomics share price is trading up by 62.5%, to 19.5 cents per share. Bionomics...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
